Jinhai Med Tech Sets 27 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express08-04

Jinhai Medical Technology Limited (Jinhai Med Tech) has announced that its board of directors will convene on 27 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026. The board will also deliberate on the declaration of an interim dividend, if deemed appropriate.

The notice, dated 4 August 2026, confirms current board composition of eight members: four executive directors—Chen Guobao (Chairman), Li Bin, Wang Zhenfei and Li Yunping; one non-executive director—Wang Huasheng; and three independent non-executive directors—Yan Jianjun, Fan Yimin and Yang Meihua.

Further details, including any dividend decision, are expected to be disclosed following the board meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment